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Treatment of experimental periodontal 
disease by laser therapy in 
simvastatin-modified rats
Low intensity laser can be used as a promising alternative in the treatment 
of periodontal disease. Objective: The aim of this study was to evaluate 
low-level laser therapy (LLLT) as an adjuvant treatment for scaling and root 
planing (SRP) for the treatment of induced periodontitis in simvastatin-
modified rats. Material and Methods: A total of 180 rats were evenly divided 
into two groups: Veh – receiving oral administration of polyethylene glycol 
(vehicle); S – receiving oral administration of Simvastatin. Periodontal disease 
was induced in both groups at the first mandibular molar. After seven days, 
the ligature was removed and the animals were divided into subgroups 
according to the following local treatments: NT – no treatment; SRP – scaling 
and root planing and irrigation with saline solution; and LLLT ¬– SRP and 
laser irradiation (660 nm; 0.03 W; 4 J). Ten animals in each subgroup/local 
treatment were euthanized at 7, 15 and 30 days. Samples of gingival tissue 
were processed to analyze the tissue oxidative damage and radiographic 
analysis. Levels of oxidative stress were analyzed by the expressions of 
Tripeptideglutathione (TG), Malondialdehyde (MDA) and Carbonylated Proteins 
(CP). Results: The animals in S group had higher levels of TG and lower levels 
of MDA and CP compared with Veh group (p<0.05). Radiographically, in the 
intragroup analysis Veh and S, LLLT showed lower bone loss (BL) compared 
with NT and SRP, in all experimental periods (p<0.01). In addition, a lower 
BL was observed for the animals of Veh group treated with LLLT compared 
with treatment SRP in the S group, in all experimental periods. Conclusion: 
Within the limits of this study, we can conclude that LLLT was effective as 
adjuvant treatment for SRP protecting against the occurrence of oxidative 
tissue damages as well as for reducing alveolar bone loss in experimentally 
induced periodontitis simvastatin-modified rats.
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Introduction
In inflammation, neutrophils are the first cells 
to be activated to defend the body together with 
macrophages27. Those are chemotaxically attracted 
by secretory cells, bacteria and other foreign bodies 
to inflammation areas27. On this site, neutrophils 
phagocyte the microorganisms, covered or not with 
complement or specific antibodies, which are killed by 
cytotoxic proteins derived from cytoplasmic granules 
and by oxygen and nitrogen reactive species such 
as superoxide anion9, hydrogen peroxide28, hydroxyl 
radical12 and peroxynitrite21.
There is evidence of a more aggressive destruction 
of tooth support tissues with elevated levels of 
oxidative stress markers during the development 
of periodontal disease (PD)24. Among the oxidants, 
the superoxide anion9, in periodontal tissues, can be 
involved in signaling of induction of bone resorption; 
the hydroxyl radical12 is extremely reactive and can 
damage important biomolecules, such as proteins, 
lipids and nucleic acids, whereas hydrogen peroxide is 
able to cross membranes, damaging adjacent cells and 
increasing the oxidative cascade28. Thus, most studies 
demonstrate that periodontitis is associated with 
increased lipid peroxidation29 and increased protein 
carbonyls9 as well as decreased antioxidants, such as 
reduced glutathione (GSH)11,29. In addition, there are 
evidences of decreased oxidative injuries and changes 
in antioxidant system following periodontal treatment19.
The treatment of PD is based on the elimination of 
pathogenic subgingival microbiota by scaling and root 
planing (SRP)24. However, mechanical therapy used 
alone may be defective in the elimination of pathogenic 
bacteria, since they are located within soft and hard 
tissues or in areas that are inaccessible to periodontal 
instruments7. In addition, an important component of 
individuals themselves can lead to tissue destruction 
observed in the periodontitis. Therefore, therapeutic 
strategies performing the pharmacological modulation 
of host response have emerged as a new therapeutic 
approach13.
Simvastatin is an inhibitor of the 3-hydroxy-3-
methyl-glutaryl-coenzyme A (HMG - CoA reductase) 
enzyme, which is responsible for the synthesis 
of cholesterol and therefore it is widely used for 
the systemic treatment of diseases related to 
hypercholesterolemia. This drug also has anti-
inflammatory, immunomodulator, antioxidant, and 
angiogenic effects6,25, and it also promotes increased 
osteoblast formation10,20. Such properties offer great 
potential for statins to modify the course of chronic 
inflammatory diseases such as periodontitis26.
In addition to drug therapy, the use of low intensity 
lasers associated with scaling and root planing for 
the local treatment of periodontal disease has been 
reported7. On the other hand, there are no studies 
evaluating the local effects of low-level laser therapy 
(LLLT) associated with the systemic effects of statins. 
Thus, the aim of this study was to evaluate LLLT as 
an adjuvant treatment for scaling and root planing 




This study was conducted on 180 adult male 
Wistar rats (200–250 g). The animals were kept 
in plastic cages with access to food and water ad 
libitum. Prior to surgical procedures, all animals were 
allowed to acclimatize to the laboratory environment 
for a period of five days. All protocols described below 
were approved by the Ethics Committee on the Use 
of Animals (CEUA), following the standards adopted 
by the Brazilian College of Animal Experimentation 
(COBEA), under protocol 472/2012.
Study design
Animals were numbered and randomly divided into 
two groups: Veh group (n=90) received Polyethylene 
Glycol 400 (All Chemistry; São Paulo, SP, Brazil) at 
0.5 mg/kg body weight (vehicle), and S group (n=90) 
received Simvastatin (Medley; Campinas, SP, Brazil) 
at 0.5 mg/kg body weight orally18. Administrations 
were daily performed in a single dose, starting 24 h 
before induction of PD and maintained until the end 
of the respective periods of euthanasia. Animals were 
weekly weighed throughout the experimental period 
to maintain the doses.
Simvastatin preparation was performed by diluting 
400 mg of the drug in 400 mlL of Polyethylene Glycol 
to reach a final concentration of 1 mg/mL (Moss 
Manipulation Pharmacy; Alfenas, MG, Brazil).
Induction of experimental periodontal disease
General anesthesia was induced by administering 
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ketamine (0.4 mL/kg) (Fort Dodge Animal Health 
Ltda; Campinas, SP, Brazil) together with xylazine 
(0.2 mL/kg) (Coopers; São Paulo, SP, Brazil) via 
intramuscular injection. The mandibular left first 
molar from each animal in both Veh and S groups was 
selected to receive a cotton ligature No. 10 (Coats; São 
Paulo, SP, Brazil) in a submarginal position to induce 
experimental periodontitis2.
Local treatment
After seven days of periodontal disease experimental 
induction, mandibular ligature was removed from the 
left first molar of all animals in groups Veh and S. 
The animals were divided into subgroups according 
to the local treatments (performed only once): NT 
– no treatment; SRP – scaling and root planing and 
irrigation with saline solution; and LLLT – SRP and 
laser irradiation.
Left molars were subjected to SRP with manual 
#1–2 micro mini five curettes (Hu-Friedy; Chicago, 
IL, USA) through 10 distal–mesial traction movements 
in both buccal and lingual aspects. The furcation and 
interproximal areas were scaled with the same curettes 
through cervical-occlusal traction movements. The 
entire SRP procedure was performed by the same 
experienced operator. The saline solutions were slowly 
deposited within the periodontal pocket using syringe 
(1 mL) and insulin needle (13 mm x 0.04 mm) (Becton 
Dickinson; Curitiba, PR, Brazil).
The laser used in this study was gallium–
aluminium–arsenide (GaAlAs) (Kondortech Equipment 
Ltd; São Carlos, SP, Brazil), with a wavelength of 
660 nm and a spot size of 0.07 cm2. After 1 min of 
saline solution application, LLLT was applied to three 
equidistant points at each buccal and lingual aspect of 
the mandibular first molar in contact with the tissue. 
The therapeutic laser was released with a power of 
0.03 W for 133 s/point, a power density of 0.428 W/
cm2, and energy of 4 J/point (57.14 J/cm2/point)7.
Experimental periods
Ten animals from each experimental subgroup/local 
treatment were euthanized by exsanguination at 7, 15 
and 30 days following local treatments. The jaws were 
removed and, in order to analyze the levels of oxidative 
stress, collections of the inserted and marginal gums 
of the buccal faces of the first left lower molars were 
performed. Then, the jaws were split in the middle 
and fixed in 10% buffered formalin for at least 48 h 
for later radiographic analysis of the left side.
Preparation of gingival samples
Gingival tissue samples were homogenized with 
phosphate buffer (3 mL, pH 6.5). The homogenate was 
centrifuged at 3500 rpm for 10 min. The supernatant 
was separated into aliquots for subsequent biochemical 
analysis.
Determination of the total protein concentration
Protein concentrations were determined in all 
samples of gingival homogenates by the method 
of Bradford4, using bovine serum albumin (BSA) 
as a standard calibration curve. The total protein 
concentration is routinely determined for normalization 
of biochemical results. Thus, the expression results 
in the mass in mg of tripeptideglutathione (TG), 
malondialdehyde (MDA) and carbonylated proteins 
(CP) per mg protein (units).
Determination of tripeptideglutathione (TG)
For verification of TG in the gingival tissue of rats 
alkylated derivatives of mBBr were separated by HPLC 
in C-18 column (Shim-pack VP-ODS, 4.6 mm x 25 cm, 
5 µm, connected in series with C-18 precolumn model 
Shim-pack GVP-ODS, 4.6 mm x 10 mm), equilibrated 
with buffer A (14.2% ethanol and 0.25% acetic acid 
m/v, 1 mL/min). Samples of tissue suspensions 
derivatized with mBBr were injected and dilution 
(buffer A) was performed for 30 min. Then, the column 
was washed with buffer B (90% methanol and 0.25% 
acetic acid) for 8 min and re-equilibrated with buffer 
A. Sulfosalicylic acid (internal reference standard), 
cysteine and reduced glutathione were determined by 
comparing the retention time of authentic standards 
(10-200 nmol) using a fluorescence detector (model 
RF-10AXL) and λexc=394 nm and λemi=490 nm (ε=20 
mM-1.cm-1), and the quantification was performed by 
counting the units in the respective areas (Software 
“LC-Solution Multi”)14.
Determination of malondialdehyde (MDA)
The MDA verification through homogenized gum 
samples was performed by adding 250 μL of 1.22 M 
phosphoric acid, 450 μL of Milli-Q Water and 250 μL 
of TBA reagent. Thereafter, aliquots are stirred for 
30 s and the reaction is incubated for 1 h in water 
bath at 95°C and cooled in ice bath at 4°C. After this 
process, 360 µL of methanol (HPLC grade) and 40 µL 
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of 1M NaOH are added to a 200 µL sample, in order to 
neutralize the solutes and precipitate proteins before 
injecting into the HPLC column, using a fluorescence 
detector (model RF-10AXL) and λexc=515 nm and 
λemi=553 nm14.
Determination of carbonylated proteins (CP)
In order to determine these CP, 500 µL of the 
aliquots in phosphate buffer (pH 7.2) may be used, 
adding 500 µL of 2.4-dinitrophenylhydrazine solution 
(10 mμ). After that, incubate for 1 h and then apply 
(drops) 500 µL of 20% TCA solution until complete 
precipitation. Add 500 µL of Ethanol/Ethyl-Acetate 
solution and centrifuge at 2000 rpm for 10 min. 
Discard the supernatant and re-add 500 µL of 
ethanol/ethyl-acetate solution and centrifuge it. Then, 
discard the supernatant and dissolve the precipitate 
with 1000 µL of 6M guanidine, which should be 
homogenized. The rate of change in absorbance was 
spectrophotometrically measured at 370 nm14.
Radiograph and digital analysis
After fixation of the hemimandibules (HMs) in 10% 
buffered formalin, the left side was submitted to X-ray 
procedure.
HMs were positioned on a table with the vestibular 
surfaces facing the radiographic film (Eastman Kodak 
Company; Rochester, Nova York, EUA), in such a way 
that the right side stayed at the bottom, and the left 
side stayed at the top.
Standardization of radiographs was obtained as 
follows:
Use of an X-ray device Pampas - E (CDK X-ray 
Equipment; Diadema, SP, Brazil), with electric system 
of 65 kvp, 10 mA;
Central X-ray beam perpendicular to the film-object 
plane, at a 90-degree angle in relation to the surface 
of the optical plate;
Focal length of 30 cm;
Exposure time of 0.8 seconds.
Radiographs were developed using solutions from 
Kodak developer and fixer, using the climate-weather 
development method.
They were scanned and the images were analyzed 
with the Imagelab software (Softium; São Paulo, 
SP, Brazil) using the tool distance and angle of 
measurement. With this feature, it was measured 
the distance from the cementoenamel junction to 
the alveolar bone crest on the mesial surface of the 
first left lower molars by drawing a line, and these 
measurements were recorded in millimeters (mm). 
The mouse was positioned on the region corresponding 
to the cementoenamel junction. By left-clicking and 
dragging the mouse down to the level of alveolar 
bone crest the software automatically measured the 
distance.
Statistical analysis
Statistical analysis of oxidative stress and 
radiographic data was performed by BioEstat 3.0 
software (Sonopress; Manaus, AM, Brazil). The 
hypothesis of absence of a statistically significant 
difference in the data obtained in the region of the 
mandibular first molars between different groups, 
subgroups/treatments and periods in the teeth with 
induced periodontitis was tested. After the analysis 
of the normality of the data by the Shapiro-Wilk 
test, multiple comparisons among the variables were 
performed by two-way analysis of variance ANOVA 
with supplementation by the Tukey test, with p<0.05 
(oxidative stress data) and by the Bonferroni test, with 
p<0.01 (radiographic data).
Results
Expression of TG in gingival samples
In the intragroup comparison (Veh and S), TG 
levels increased significantly (p<0.05) between the 
experimental periods in all local treatments. Regarding 
local treatments, LLLT showed a significant increase 
(p<0.05) in GSH compared with NT and SRP at 7 and 
30 days.
In the comparison between the groups (Veh and 
S), among the same local treatments, TG levels in 
the S group were significantly higher than those in 
the Veh group (p<0.05), for NT, SRP and LLLT in all 
experimental periods (Table 1).
Expression of MDA in gingival samples
In the intragroup comparison, levels of MDA in LLLT 
decreased significantly (p<0.05) compared with NT, 
in the S group in all experimental periods, and in the 
Veh group at 7 and 30 days.
In the comparison between the groups (Veh and 
S), among the same local treatments, MDA levels in S 
group were significantly lower than those in Veh group 
(p<0.05), for NT, SRP and LLLT at 7 days (Table 2).
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Group Veh
Periods 7 days 15 days 30 days
Treatments
NT 5.02±0.24#*´° 10.99±0.30#´° 22.17±1.21#*´°
SRP 8.52±1.00 #*´° 15.01±0.30#´° 40.76±1.98#*´°
LLLT 10.13±1.13#*´° 16.07±1.64#´° 52.49±0.58#*´
Group S
Periods 7 days 15 days 30 days
Treatments
NT 14.15±0.34#*´° 23.11±1.67#´° 43.87±0.56#*´°
SRP 17.43±0.02#*´° 26.79±1.02#´° 54.97±1.02#*´°
LLLT 23.29±0.17#*´° 24.32±1.09#´° 64.98±1.12#*´°
N 60 60 60
#Difference among  same groups and local treatments (ANOVA and p<0.05)
*Difference between local treatments, same group and period (ANOVA and Tukey, p<0.05)
´Difference between groups, same local treatment and period (ANOVA and Tukey, p<0.05)
°Difference between groups and local treatments, same period (ANOVA and Tukey, p<0.05)
Table 1- Means and standard deviations (M±SD) expression in TG units in the gingival tissue of the first lower left molar, according to each 
group, local treatment and period
Group Veh
Periods 7 days 15 days 30 days
Treatments
NT 0.18±0.06´° 0.24±0.12° 0.30±0.03°
SRP 0.28±0.12´° 0.40±0.09 0.62±0.13*
LLLT 0.48±0.32*´° 0.47±0.43* 0.34±0.17°
Group S
Periods 7 days 15 days 30 days
Treatments
NT 0.34±0.07´° 0.36±0.16 0.44±0.08° 
SRP 0.53±0.22´° 0.38±0.65 0.61±0.73*° 
LLLT 0.72±0.54*´° 0.44±0.33*° 0.41±0.98°
N 60 60 60
#Difference among  same groups and local treatments (ANOVA and p<0.05)
*Difference between local treatments, same group and period (ANOVA and Tukey, p<0.05)
´Difference between groups, same local treatment and period (ANOVA and Tukey, p<0.05)
°Difference between groups and local treatments, same period (ANOVA and Tukey, p<0.05)
Table 2- Means and standard deviations (M±SD) expression in MDA units in the gingival tissue of the first lower left molar, according to 
each group, local treatment and period
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Group Veh
Periods 7 days 15 days 30 days
Treatments
NT 13.23±0.31+*´° 8.45±1.56+* 7.89±1.95*°
SRP 7.02±0.31+*´° 2.39±1.13+*° 3.92±0.06+*°
LLLT 4.71±0.23+*´° 1.99±0.94+*° 2.37±0.18+*°
Group S
Periods 7 days 15 days 30 days
Treatments
NT 9.78±.3+*´° 7.99±11.3+*° 5.21±0.04+*°
SRP 1.29±1.16+*´° 4.80±1.12+*° 3.92±1.00+*°
LLLT 1.57±0.95+*´° 3.41±1.04+*° 1.09±0.32+*°
N 60 60 60
#Difference among  same groups and local treatments (ANOVA and p<0.05)
*Difference between local treatments, same group and period (ANOVA and Tukey, p<0.05)
´Difference between groups, same local treatment and period (ANOVA and Tukey, p<0.05)
°Difference between groups and local treatments, same period (ANOVA and Tukey, p<0.05)
Table 3- Means and standard deviations (M±SD) expression in CP units in the gingival tissue of the first lower left molar, according to each 
group, local treatment and period
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Expression of CP in gingival samples
In the intragroup comparison (Veh and S), levels of 
CP in LLLT decreased significantly (p<0.05) in relation 
to NT in all the experimental periods.
In the comparison between Veh and S groups, 
among the same local treatments, CP levels in the S 
group were significantly lower than those in the Veh 
group (p<0.05), for NT, SRP and LLLT at 7 days. In 
addition, CP levels in the Veh group, treated by LLLT, 
were significantly lower than those in the S group 
(p<0.05), which did not receive local treatment (NT) 
at 7 and 15 days (Table 3).
Radiographic analysis
In the intragroup analysis between Veh and S, 
LLLT showed lower BL compared with NT and SRP, in 
all experimental periods (p<0.01).
In the intergroup analysis between the same local 
treatments, the SRP presented a lower BL (p<0.01) in 
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Group Veh
Periods 7 days 15 days 30 days
Treatments
NT 2.97±0.21+*° 2.53±0.34+*° 2.06±0.13+*°
SRP 1.88±0.31+*´° 1.83±1.06*° 1.51±0.19+*°
LLLT 0.63±1.17*° 0.58±0.93*° 0.49±1.34*°
Group S
Periods 7 days 15 days 30 days
Treatments
NT 2.65±0.33+*° 2.37±0.43+*° 1.74±0.97+*°
SRP 1.61±0.45*´° 1.49±0.56*° 1.36±1.31*°
LLLT 0.57±0.78*° 0.50±0.55*° 0.47±0.88*°
N 60 60 60
#Difference among periods, same groups and local treatments (ANOVA and Bonferroni, p<0.01)
*Difference between local treatments, same group and period (ANOVA and Bonferroni, p<0.01)
´Difference between groups, same local treatment and period (ANOVA and Bonferroni, p<0.01)
°Difference between groups and local treatments, same period (ANOVA and Bonferroni, p<0.01)
Table 4- Means and standard deviations (M±SD) of the distances between the cementoenamel junction and alveolar bone crest (mm) on 
the mesial surface of the first lower left molar, according to each group, local treatment and period
Figure 1- Radiographic images of the hemimandibules of animals of the Veh group – A: NT 7 days; B: NT 15 days; C: NT 30 days; D: SRP 
7 days; E: SRP 15 days; F: SRP 30 days; G: LLLT 7 days; H: LLLT 15 days; and I: LLLT 30 days
Figure 2- Radiographic images of the hemimandibules of animals of the S group – A: NT 7 days; B: NT 15 days; C: NT 30 days; D: SRP 
7 days; E: SRP 15 days; F: SRP 30 days; G: LLLT 7 days; H: LLLT 15 days; and I: LLLT 30 days
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the animals of the S group (1.61±0.45 mm) compared 
with those in the Veh group (1.88±0.31 mm) in the 
7-day period.
In the S group, LLLT values (0.57±0.78 mm, 
0.50±0.55 mm, 0.47±0.88 mm) showed lower BL 
(p<0.01) compared with animals of the Veh group 
treated with SRP (1.88±0.31 mm, 1.83±1.06 mm, 
1.51±0.19 mm) in all experimental periods. In 
addition, a lower BL was observed for the animals 
of the Veh group treated with LLLT (0.63±1.17 mm; 
0.58±0.93 mm; 0.49±1.34 mm) compared with SRP 
treatment in the S group (1.61±0.45 mm; 1.49±0.56 
mm; 1.36±1.31 mm), in all experimental periods 
(Table 4, Figure 1 and Figure 2).
Discussion
Periodontal disease is a chronic inflammatory 
process characterized by gingival bleeding, 
formation of periodontal pockets and destruction of 
periodontal supporting tissues, through the release of 
lipopolysaccharide and proteases27 of bacteria present 
in the dental biofilm, a key etiological factor of this 
change. This tissue inflammation is associated with 
increased release of oxygen reactive species (ORS) 
by neutrophils, and also with the activation of several 
inflammatory mediators, such as interleukins (IL-1β, 
6 and 8) and tumor necrosis factor (TNF-α)11, which 
promotes the imbalance in bone homeostasis, resulting 
in destruction of alveolar bone tissue, increased 
activity of matrix metalloproteinases and connective 
tissue degradation17, due to exacerbated immune 
response and localized osteoclastogenesis12.
Periodontal treatment is used to paralyze the 
destruction of the supporting tissues of the teeth in 
order to avoid their loss5. However, there are cases 
where isolated periodontal mechanical therapy is 
ineffective, suggesting that systemic factors, not yet 
understood, could interfere with the development of 
the disease22. Thus, the use of antioxidants could be 
an adjuvant therapy to conventional treatment17.
Simvastatin is a drug with hypolipidemic function, 
but it stands out for other minor effects, including anti-
inflammatory25, immunomodulatory, and antioxidant 
effects, and the promotion of angiogenesis and 
increased differentiation of osteoblasts, inducing bone 
formation10,20. Such properties offer great potential for 
statin to modify the course of chronic inflammatory 
diseases26 such as chronic periodontitis.
Ligature-induced alveolar bone loss may occur due 
to abnormal activation of the host’s immune system27. 
This will result in an imbalance, leading to an excessive 
production of oxidants and inhibiting the formation 
of antioxidants, which will cause the development of 
oxidative stress11. The association between systemic 
oxidative stress and periodontal disease in human 
and animal studies has been described in a review 
of the literature by Tomofuji, et al.28 (2011). This 
author mentioned that there is a correlation between 
the production of oxidants in sites with periodontal 
disease and the development of lesions in various 
organs of the body.
In animals, the association between ORS/
nitrogen reactive species (NRS) in sites of induced 
periodontitis is well established. With the use of an 
experimental model induced by topical application of 
lipopolysaccharide and specific proteases to the gums, 
Tomofuji, et al.28 (2011) showed a clear correlation 
between the severity of periodontal disease and 
oxidative lesions in the liver tissues and descending 
aorta. This oxidative stress can be evaluated in several 
ways such as by measuring the ORS levels, damages 
to nucleic acids, proteins and lipids, and detecting the 
levels of antioxidants3.
In this context, the proposed experimental model 
evaluated the concentration of TG, an endogenous 
antioxidant, and our results demonstrated that in 
both groups (Veh and S) NT showed significantly 
reduced levels compared with SRP and LLLT. This 
fact demonstrated that the development of oxidative 
damage occurred as well as in another study described 
in the literature using experimental periodontitis in 
rats11.
Another widely used method for determining the 
occurrence of oxidative damage mediated by ORS in 
tissues is the measurement of MDA3. Studies have 
demonstrated an association between periodontitis 
and increased MDA in samples of gingival fluid, saliva 
and gingival tissue11,28. In the intragroup comparison 
we observed that levels of MDA in NT were significantly 
higher (p<0.05) compared with LLLT, in the S group in 
all experimental periods, and in the Veh group at 7 and 
30 days. These results demonstrate that MDA is a good 
marker of oxidative stress. Our results corroborate 
other studies11,23, which report that lipid peroxidation is 
a very common example of oxidative stress in induced 
periodontitis and that its increase plays an important 
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role in the progression of periodontal destruction3.
 The CP analysis is another way to verify the 
presence of oxidative tissue damage with changes 
mediated by inflammatory processes. In this model 
we observed a significant decrease in CP in the LLLT 
in the S group compared with NT and SRP in Veh 
group (p<0.05). This is probably due to the anti-
inflammatory effects of LLLT and simvastatin. A study 
carried out in 200316 reinforced this hypothesis, since 
it demonstrated that simvastatin was able to inhibit 
the secretion of matrix metalloproteinases. Thus, they 
could reduce the inflammatory response, providing 
protection against the destruction of periodontal 
tissue. In humans, some studies have established 
that chronic periodontitis is directly correlated with 
the high occurrence of oxidative damage to proteins, 
determined by the measurement of serum CP as 
well as the increase in total oxidant status and lipid 
peroxidation products, quantified as MDA15,30. Whereas 
regarding LLLT, it was observed that it inhibited the 
production of inflammatory mediators1.
In the intragroup analysis between Veh and S 
groups, LLLT showed lower BL compared with NT and 
SRP in all experimental periods (p<0.01). These results 
demonstrate that SRP was not effective in controlling 
bone loss in the furcation areas of animals. Clinically, 
it is proved that SRP with hand tools provides the 
best results for the treatment of periodontal disease. 
However, several factors may limit the success of SRP 
such as root concavities, dental crowding, deep areas, 
and areas of bifurcation that hinder the access of hand 
tools in the periodontal pocket. Due to these limiting 
anatomic factors, therapies to support conventional 
treatment have been proposed15.
Therefore, in this study simvastatin was chosen, 
since statins have different effects on bone, such as 
increased bone formation, whereas lovastatin and 
pravastatin have a smaller effect than simvastatin, 
atorvastatin and cerivastatin10. In addition, it 
stands out for acting in important events during an 
exacerbated inflammatory response. In the intergroup 
analysis between the same local treatments, the SRP 
presented a lower BL (p<0.01) in the animals of the 
S group compared with those in Veh group in the 
7-day period. In S group, LLLT values showed lower 
BL (p<0.01) compared with animals of Veh group 
treated with SRP in all experimental periods. This result 
is in agreement with other studies3,10,15. According to 
Luan, et al.16 (2003) statins decrease the production 
of many pro-inflammatory cytokines and have also 
been described as promoting decreased secretion of 
MMP-1 (matrix metalloproteinase - 1), MMP-2, MMP-3 
and MMP-9 in vitro. Thus, they could reduce strong 
immune response, protecting against the destruction 
of periodontal tissue.
In addition, a lower BL was observed for the animals 
of the Veh group treated with LLLT compared with SRP 
treatment in the S group, in all experimental periods, 
confirming previous studies5,7 that demonstrate a 
better outcome of periodontal treatment with this 
combination, by stimulating bone formation7,8,22. These 
studies have reported that the use of this light source 
inhibits the production of inflammatory mediators 
by cells of the periodontal ligament, promotes 
cell chemotaxis, and promotes local angiogenesis 
and vasodilation, and therefore there could be an 
increase in tissue oxygen diffusion, promoting the 
repair process, because the secretion of collagen 
by fibroblasts in the extracellular space only occurs 
in the presence of high rates of oxygen pressure1. 
However, in a meta-analysis study23, the results 
showed no difference when comparing the treatment 
of periodontal disease through SRP or in combination 
with lasers. These conflicting results may be due to 
methodological differences, mainly in relation to the 
protocols of laser used and to the different irradiation 
parameters used.
Among the limitations of the study, we can mention 
the fact of being carried out in animals, and it is not 
prudent to extrapolate the results to the human 
species, for further studies in the literature would be 
necessary.
Conclusion
Within the limits of this study, we can conclude 
that LLLT was effective as adjuvant treatment for 
SRP protecting against the occurrence of oxidative 
tissue damages as well as reducing alveolar bone loss 
in experimentally induced periodontitis simvastatin-
modified rats.
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